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Abstract
Anthrax threatens human and animal health, and people’s livelihoods in many rural commu-
nities in Africa and Asia. In these areas, anthrax surveillance is challenged by a lack of tools
for on-site detection. Furthermore, cultural practices and infrastructure may affect sample
availability and quality. Practical yet accurate diagnostic solutions are greatly needed to
quantify anthrax impacts. We validated microscopic and molecular methods for the detec-
tion of Bacillus anthracis in field-collected blood smears and identified alternative samples
suitable for anthrax confirmation in the absence of blood smears. We investigated livestock
mortalities suspected to be caused by anthrax in northern Tanzania. Field-prepared blood
smears (n = 152) were tested by microscopy using four staining techniques as well as poly-
merase chain reaction (PCR) followed by Bayesian latent class analysis. Median sensitivity
(91%, CI 95% [84–96%]) and specificity (99%, CI 95% [96–100%]) of microscopy using azure
B were comparable to those of the recommended standard, polychrome methylene blue,
PMB (92%, CI 95% [84–97%] and 98%, CI 95% [95–100%], respectively), but azure B is more
available and convenient. Other commonly-used stains performed poorly. Blood smears
could be obtained for <50% of suspected anthrax cases due to local customs and condi-
tions. However, PCR on DNA extracts from skin, which was almost always available, had
high sensitivity and specificity (95%, CI 95% [90–98%] and 95%, CI 95% [87–99%], respec-
tively), even after extended storage at ambient temperature. Azure B microscopy represents
an accurate diagnostic test for animal anthrax that can be performed with basic laboratory
infrastructure and in the field. When blood smears are unavailable, PCR using skin tissues
provides a valuable alternative for confirmation. Our findings lead to a practical diagnostic
approach for anthrax in low-resource settings that can support surveillance and control
efforts for anthrax-endemic countries globally.
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Author summary
Anthrax, an ancient disease largely controlled in the developed world, is still widespread in
remote and rural communities of low- and middle-income countries where it affects human
and animal health, and livelihoods. To control anthrax effectively, detection and accurate
confirmation are important, but solutions need to be feasible for the most-affected areas
where resources and infrastructure are typically limited. To achieve this, we assessed a newly
proposed stain, azure B, for microscopic confirmation on animal blood smears, as this
method can be implemented in low-resource laboratories and in the field. Microscopy using
azure B was highly accurate compared to other recommended stains and has the added
advantage of being more readily available and convenient. However, blood smear samples
were unavailable for more than half of suspected cases. We therefore evaluated a molecular
test (PCR) on other sample types–whole blood, blood swabs, skin, and flies–stored at ambi-
ent temperature. We show high performance of PCR with skin tissues which were available
for 90% of carcasses. Thus, under field conditions, smear samples (when available) and tis-
sue samples are most suitable for diagnostic testing of animal anthrax, whereby microscopy
can be conducted in affected areas and PCR in in-country reference laboratories.
Introduction
Zoonotic diseases have a dual and high burden on the health and livelihoods of people, in addi-
tion to their impact on animal health and welfare. The livelihoods of the majority of people liv-
ing in developing countries depend on livestock farming, and it is estimated that about 80% of
households in Africa derive all or part of their income from livestock keeping [1]. Therefore,
the control of zoonotic diseases that cause human and animal ill-health–as well as losses to
livelihoods–is important and highly relevant to achieving the Sustainable Development Goals
[2]. In contrast to emerging diseases, endemic zoonotic diseases like anthrax do not receive
the attention needed to control them [3,4]. Anthrax is a bacterial disease caused by Bacillus
anthracis and primarily affects herbivorous mammals, where it is characterised by sudden
deaths in otherwise healthy animals.
In many parts of the developing world, underdiagnosis and misdiagnosis are important rea-
sons for limited availability of data on the prevalence, incidence and impact of endemic diseases
[3–5]. Confirmation of anthrax through detection of B. anthracis in an animal carcass can be
achieved by examination of a stained blood smear, or by culture or polymerase chain reaction
(PCR). Culture and (or) PCR are considered to be superior compared to microscopy [6], but
require infrastructure and consumables that few laboratories in developing countries have
access to. For example, culture must be carried out in laboratory facilities equipped at biosafety
level (BSL) 2+ or ideally level 3, which are commonly lacking in areas where anthrax is endemic.
Besides the higher costs associated with culture, the occurrence of anthrax in very remote and
challenging environments might mean that samples collected are not viable for culture when
they eventually reach the laboratory, as B. anthracis is easily outcompeted by many other bacte-
rial species [6]. Tests that perform highly on both scientific and convenience criteria are desir-
able; this is especially true in areas where resources are scarce, and infrastructure is limited.
Scientific criteria encompass the ability of a test to distinguish between subjects when the condi-
tion under investigation is truly present or absent, while convenience criteria are related to ease
or practicality of implementing the test [7]. Convenience and scientific criteria are reflected in
WHO’s recommendation of ASSURED tests for developing countries (Affordable, Sensitive,
Specific, User-friendly, Rapid and robust, Equipment free, and Deliverable to those who need
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it) [8]. WHO recommends culture and PCR as the methods of choice for confirmation of
anthrax because of their high performance in terms of scientific criteria, but these methods are
lacking in convenience criteria, particularly in the context of anthrax-endemic countries. In
contrast, smear stain microscopy is a rapid and simple method for detecting B. anthracis requir-
ing minimal equipment. It therefore holds great potential value as a field-friendly diagnostic
method for anthrax confirmation in low-resource settings. Smear stain microscopy meets many
of the ASSURED convenience criteria, however little is known about its performance against
scientific criteria for the detection of B. anthracis for animal anthrax confirmation.
In 1903, M’Fadyean [9] established capsule staining with polychrome methylene blue
(PMB) as a specific technique to detect B. anthracis and confirm anthrax. The capsule is a key
component of B. anthracis’ complex surface structure and contributes to the pathogenicity and
virulence of the bacterium [10]. The capsule is a specific feature of B. anthracis and is not usu-
ally produced by closely related bacteria in the same genus such as B. cereus and B. thuringien-
sis [11]. Although M’Fadyean PMB staining is the generally-accepted reference standard
method for anthrax confirmation by microscopy, quality-controlled PMB has been difficult to
obtain commercially since the successful control of anthrax in developed countries [12]. In
addition, the stain requires at least 12 months to ‘age’ in order to develop its metachromatic
property, i.e. its ability to distinctly stain the capsule [12,13]. These limitations often prevent
the rapid confirmation of anthrax in the field. One of the derivatives of PMB–azure B–has the
potential to mitigate the limitations of PMB, as it is readily available and does not require mat-
uration before use. The potential of azure B has been assessed under laboratory conditions on
a limited number of smears prepared from isolates of B. anthracis from goats and mice [12],
but no studies have assessed the stain directly on field samples obtained in endemic settings.
Smear samples are one of the easiest samples to collect and store. This makes them useful
where infrastructure for cold chain storage is lacking. However, in areas where anthrax-suspect
carcasses may be used by humans for food [14–16] or consumed by scavengers [17,18], smear
samples may be difficult to obtain for microscopy. PCR testing using other sample types pro-
vides an alternative when laboratory infrastructure is available in-country, although it may not
meet some of the ASSURED criteria. For instance, it is more expensive, time consuming and
requires more equipment and technical expertise than microscopy. Molecular detection of B.
anthracis using PCR is a highly specific method to identify the pathogen [19]. However, for
animal anthrax, PCR has largely been applied to DNA extracts from B. anthracis isolates
[19,20], rather than field samples. Confirmation of anthrax from animal tissue samples has
been reported using wildlife samples that had been stored in formaldehyde and cryopreserved
in liquid nitrogen [21]. There have been no systematic studies to assess both sensitivity and
specificity of PCR directly on various sample types, especially those that may be collected
under typical field conditions. In addition, it is unknown whether PCR could be conducted on
material from slides with stained blood smears, as histological stains may damage B. anthracis
DNA or affect its integrity or quality, e.g. by intercalating between the genetic material.
Bacterial culture followed by confirmatory tests–including phage and penicillin sensitivity,
and PCR to detect genes specific to B. anthracis–is currently considered the gold standard
approach for the diagnosis of anthrax [6]. Although PCR may detect B. anthracis directly
from samples where culture has been unsuccessful [22], neither direct PCR, which to our
knowledge has rarely been implemented in field settings, nor microscopy are considered gold
standard methods for the detection of B. anthracis. Therefore, it is important to determine
their sensitivity and specificity if they are to be employed to improve the surveillance of
anthrax in endemic and resource-poor areas. This study was aimed at testing and providing
practical recommendations for the detection of B. anthracis from suspect animal carcasses in
resource-poor endemic settings where culture is not feasible. To achieve this aim, our study
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objectives were to 1) validate the newly proposed azure B staining technique for use on field
samples by comparing its sensitivity and specificity to PMB and other routinely used stains; 2)
assess the feasibility of using stained and unstained smears in PCR-based anthrax confirma-
tion; and 3) determine the suitability of different sample types for molecular detection of B.
anthracis using quantitative PCR (qPCR).
Methods
Study area
This study was carried out in the Ngorongoro Conservation Area (NCA) of northern Tanzania
(Fig 1). The NCA covers an area of 8,292 km2 and had 70,084 inhabitants in 2012, with a popu-
lation growth rate of 2.7% [23]. The major ethnic group in the study area are the Maasai who
practise traditional nomadic pastoralism. The NCA is a multiple-use area where people and
animals (including wildlife and livestock) co-exist and it typifies many rural settings in Africa
and elsewhere in the world, including the multitude of risks and challenges to the control of
neglected diseases. Some of the common characteristics of these settings include the remote-
ness of communities, the unavailability of well-developed infrastructure, and the co-existence
of people and animals. Anthrax is present in the NCA and outbreaks are reported more fre-
quently in the area in comparison to other regions [24,25]. Our ongoing active surveillance
(since 2016) in the NCA indicates that the disease is much more widespread in humans and
animals than reflected in official reports, with regular cases throughout the year. This provides
an ideal setting for assessing the performance of anthrax diagnostic tests.
Ethics statement
The study received approval from the Kilimanjaro Christian Medical University College Ethics
Review committee with certificate No. 2050; National Institute for Medical Research (NIMR),
Tanzania, with Reference Number NIMRJHQ/R.8a/Vol. IX/2660; Tanzanian Commission for
Fig 1. Tanzania, with the study area for evaluating anthrax diagnostic tools, the Ngorongoro Conservation Area
(NCA), shown in grey. The NCA is a multiple land use area where people, livestock and wildlife live in close proximity
and anthrax is endemic. Map was produced using data from Tanzania Bureau of Statistics.
https://doi.org/10.1371/journal.pntd.0008655.g001
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Science and Technology (COSTECH) number 2016-94-NA-2016-88; and College of Medical
Veterinary and Life Sciences ethics committee at the University of Glasgow (application num-
ber 200150152). Approval and permission to access communities were also obtained from rel-
evant local authorities. Verbal and/or written informed consent was obtained from all owners
of livestock sampled after explaining the study objectives. Verbal consent was obtained in lieu
of written consent where participants were unable to write. Both verbal and written consent as
well as the participant information sheet had been approved by the ethical committees.
Field-based surveillance and sampling
We set up a field-based active surveillance system within the NCA to investigate deaths in live-
stock reported by community members suspected to be caused by anthrax, and to obtain sam-
ples for disease confirmation based on the identification of B. anthracis. Twenty-five local
animal health professionals including community animal health workers (CAHWs) and live-
stock field officers (LFOs) were trained to respond to reports of anthrax cases in the NCA and
to collect samples for confirmation. Suspected cases of anthrax in animals were defined as the
occurrence of sudden death in previously healthy-looking animals, possibly with associated
signs such as blood oozing from the natural orifices and the rapid swelling and decomposition
of carcasses. We adapted this definition for wildlife to include carcasses 1) that were suffi-
ciently intact to observe these signs and to preclude death from starvation or predation, and 2)
in situations where several wildlife deaths had occurred in an area within a short span of time,
suggestive of a disease outbreak. The professionals received sampling kits containing materials
for sample collection and personal protective equipment (PPE). Each kit contained primary
containers (30 ml Sterilin containers for tissues, soil, flies and swabs, or 5 ml blood tubes for
whole blood), secondary containers (Ziplock bags), in addition to slides for blood smear sam-
ples, a disposable scalpel and a pair of disposable forceps. The PPE included two pairs of
gloves, a face mask, over-sleeves and cover boots, and chlorine release tablets (to be dissolved
in water to obtain approximately 10,000 ppm chlorine solution) for decontamination.
Unless otherwise stated, all individual samples were collected into primary containers, then
sealed within secondary Ziplock bags. Five sample types were obtained. Firstly, blood smear
samples were collected from anthrax-suspect carcasses when blood was available for smearing.
In the field at the site of the carcass, blood was smeared onto a slide using a second slide (up to
6 per carcass). Smears were air dried, and slides were carefully wrapped in paper towel and
sealed in primary Ziplock bags. Secondly, when available, whole blood was collected using nee-
dle-free syringes, transferred into blood tubes with no anticoagulant, wrapped in paper towel
and sealed in a secondary container. Thirdly, swab samples were taken by inserting a cotton
swab into available blood or fluids from a carcass. Fourthly, depending on the state of the ani-
mal remains, tissue was collected from the tip of the ear (if the carcass was still intact) or other
available pieces of skin (if they had been butchered or scavenged) (Fig 2). Skin was collected
using disposable scalpel and forceps. Finally, flies on and around carcasses and areas where the
animals had been butchered or scavenged were collected into tubes. All sample types from a
single carcass were packaged in a larger tertiary Ziplock bag and stored at ambient temperature
(15˚C to 47˚C in the NCA) prior to transporting to the Kilimanjaro Clinical Research Institute
(KCRI) laboratory in Moshi, Tanzania, for testing. Samples were stored at ambient tempera-
ture for up to six months before testing.
Microscopy testing
For each carcass sampled between June 2016 and November 2017 (n = 152), three stains
(azure B, Giemsa and Rapi-Diff II) were applied to smear samples (one stain per sample). PMB
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staining was carried out on a subset of the total carcasses (n = 102) due to smear sample
unavailability. One positive control slide obtained from the Rare and Imported Pathogens Lab-
oratory (RIPL), Public Health England (PHE), was included in each staining batch of up to 12
slides. The control slides consisted of smears of B. anthracis isolated from pure culture, fixed
in formalin and heat inactivated as per standard procedures carried out by PHE. The staining
procedures are outlined in S1 File.
Stained slides were examined using a light microscope (magnification 1000x), in random
order with respect to the staining technique. Smears were considered positive if blue or purple
square-ended rods were observed surrounded by a pink or pinkish-red capsule or ‘shadon’, a
remnant of capsular material [26] (S1 Fig). A slightly modified protocol, based on [12], was
used to define the quality and strength of capsule presence based on the metachromatic prop-
erty of the stains and the ability to clearly demarcate the capsule from the cells. Scores were
assigned to each slide based on the chart shown in S1 Fig.
Inter-observer and inter-laboratory comparison. To measure inter-observer variability,
which might affect the utility of the test in non-specialist settings, comparisons of slide read-
ings made by multiple observers were carried out. Firstly, a batch of slides stained by one per-
son was viewed and interpreted by two observers. One of the observers, who had previous
microscopy experience, but had not been involved in routine B. anthracis diagnostics, was
briefly trained to identify the morphological characteristics of this pathogen. Observations
were carried out on slides that were used to assess the performance of the four stains. Secondly,
for azure B only, the two people independently stained and read slides made from the same
animal cases (n = 71).
For a subset of suspected anthrax cases, additional blood smear samples (n = 66) were
assessed independently by the Tanzania Veterinary Laboratory Agency (TVLA) zonal veteri-
nary centre in Arusha, Tanzania, which is responsible for veterinary diagnostic services
within the study region. Here, smears were processed by laboratory personnel following their
Fig 2. Examples of suspected Bacillus anthracis-infected carcasses sampled as part of a field-based surveillance scheme in northern
Tanzania. Blood smears, whole blood, blood swabs and skin were obtainable from a), whereas only skin could be obtained from b).
https://doi.org/10.1371/journal.pntd.0008655.g002
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routinely used protocol with PMB stain, prepared at the TVLA and aged for 4 years. This pro-
cedure is hereafter referred to as the TVLA technique.
DNA extraction and quantitative PCR testing
All procedures related to sample aliquoting and DNA extraction were carried out in a class 2
biosafety cabinet at a biocontainment level 3 facility at KCRI. Sterile filter pipette tips were
used throughout all extractions.
DNA extraction. DNA extraction was conducted using the Qiagen DNeasy Blood & Tis-
sue Kit (Qiagen, Germany) spin column protocol, with initial sample preparation conducted
as outlined below.
Smear scrapings were collected in a 1.5 ml microcentrifuge tube. After this, 200 μl PBS and
20 μl of 20 mg/ml proteinase K were added to the tubes. For blood samples, 20 μl proteinase K
was pipetted into a 1.5 ml microcentrifuge tube. A 100 μl aliquot of the blood sample was
transferred into the tube containing proteinase K, and the solution adjusted to 220 μl by add-
ing 100 μl of phosphate buffered saline (PBS). For swabs, the sampled end was cut off and
placed into a 1.5 ml microcentrifuge tube and soaked in 200 μl PBS with 20 μl proteinase K.
The mixture was incubated at ambient temperature for at least one hour, vortexing the tubes
mid-way and after incubation. For skin, a portion (approximately 50 mg) was cut into small
pieces of approximately 2 mm3 in a petri dish using a sterile scalpel and transferred into a 2 ml
MagNA Lyser bead tube (Roche, United Kingdom). Following this, 360 μl tissue lysis buffer
(ATL buffer, included in the Qiagen kit) was added to each tube and the sample was bead
beaten four times at 5000 rpm for 18 seconds in a Precellys tissue homogeniser (Bertin,
France). Proteinase K (40 μl) was added to the mixture and left to incubate at 56 ˚C for 6 to 8
hours or overnight until complete tissue lysis was achieved. For flies, about 100 mg (between 1
and 3 individuals) were transferred into a 2 ml MagNA Lyser bead tube and 360 μl of PBS was
added. The sample was bead beaten four times at 5000 rpm for 18 seconds in a Precellys tissue
homogeniser and 200 μl of the homogenised sample was transferred into a microcentrifuge
tube with 20 μl of proteinase K added. For all these sample types, the supernatant (220 μl) was
transferred to a new microcentrifuge tube and the DNeasy Blood & Tissue Kit spin column
protocol was completed according to the manufacturer’s protocol. No-template controls were
included in each extraction by taking only reagents through the extraction process. All DNA
extracts were stored at -20˚C prior to use in PCR. The fly species were not determined prior to
DNA extraction.
qPCR. Quantitative PCR was carried out on all DNA extracts. Taqman (hydrolysis)
probe-based assays were carried out on the Rotor-Gene Q platform (Qiagen), targeting one
chromosomal sequence (PL3) [19] and two plasmid targets, cap (pXO2) and lef (pXO1).
Primer and probe sequences for the plasmid targets were obtained from RIPL, PHE. Details
are available as supplementary materials in S1 Table
Master mix was prepared as follows: 10 μl 2X PrimeTime Gene Expression Master Mix
(IDT, Belgium), 10 μM primers and probes (volumes according to S1 Table) and made up to
18 μl per reaction with nuclease free water. The mixture was vortexed and centrifuged briefly.
Master mix was added to each qPCR tube and 2 μl of the template DNA was added for a total
reaction volume of 20 μl. Negative and positive qPCR controls for each target were included in
each run. The cycling conditions were as follows: (1) activation/denaturation at 95˚C for 3
minutes, and (2) amplification, using 40 cycles of 60˚C for 35 seconds and 95˚C for 5 seconds.
qPCR on DNA extracts from stained smears. For 15 carcasses testing positive for B.
anthracis by microscopy and qPCR (based on material from unstained slides), DNA was
extracted from each of the 4 stained slides to test whether staining interferes with the qPCR
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process. The smear from each slide was scraped off, the DNA was extracted, and qPCR con-
ducted as described above. Primers and probes for only the chromosomal target were used in
the qPCR reaction. The cycle threshold (Ct) values for stained smear samples were compared
to values for unstained samples. For each stain, 2 PHE controls were included.
Estimating test sensitivity and specificity
Analyses for estimating the sensitivity and specificity of the tests were conducted assuming the
unavailability of a gold standard test by employing latent class analyses [7] within a Bayesian
framework. A Latent Class Model (LCM) was applied assuming two latent classes for each of
the anthrax-suspect cases studied–anthrax true positive and anthrax true negative carcasses.
The LCM formulation that we used is equivalent to an extension of the standard Hui Walter
model [27], but our formulation is more similar to that of a state space model where there is a
formal separation of the observation layer and the underlying process layer. This type of
model can also be considered a generalised form of a mixture model in which the latent classes
are related to each other in some way rather than being independent [28]. The analysis used
test results from the four different staining techniques and qPCR carried out on blood smear,
whole blood, blood swab, and skin tissue samples. A breakdown of the data informing the
LCM is shown in Fig 3.
The latent class model estimated the true but latent disease status of each sampled animal as
a Bernoulli distribution based on the prevalence of B. anthracis within the population of car-
casses. This depended on the underlying process (i.e. the presence of capsule or DNA within a
sample from an animal infected with B. anthracis), which was modelled as a second latent pro-
cess conditional on the true disease status of the corresponding animal, and the observation
process (i.e. the test ability to detect the DNA or capsules in the sample as observed in the PCR
Fig 3. Workflow for samples and data informing the latent class model used to estimate the sensitivities and specificities of
different tests used in the diagnosis of suspected anthrax carcasses.
https://doi.org/10.1371/journal.pntd.0008655.g003
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and microscopy test results). Minimally informative priors were imposed on the model for the
prevalence of B. anthracis as no relevant published studies on the prevalence of anthrax (i.e.
the proportion of sudden deaths attributable to anthrax) in livestock in Tanzania are available.
The prior for prevalence was a Beta (1, 1) distribution. Minimally informative priors were also
used for the probability of observing a capsule if present (independent of the stain used), the
sensitivities of the four staining techniques, the probability of detecting DNA if present, and
the sensitivity of the PCR test. Each of those priors was set to Beta (1, 1).
Much more informative priors were imposed on the model for the specificities of the four
staining techniques. This assumed that observing a capsule on a bacillus or chain of bacilli in a
sample from a suspected anthrax case was very specific for B. anthracis, so the specificities of
the test based on this criterion should be high. Thus, Beta (50, 1) indicating specificities
between 92% to 100% was used as prior for each of the four staining techniques. For the speci-
ficity of PCR, a prior indicating specificity between 92% to 100% (Beta (50, 1)) was also applied
to the model. For the underlying processes implying that the presence of the DNA targets and
capsule indicate B. anthracis infection, priors were Beta (371, 1) and Beta (50, 1), respectively.
The model was fitted using Markov chain Monte Carlo (MCMC) methods implemented
using JAGS [29], called from R, version 3.6.0 [30] using the runjags package [31] as an inter-
face. For the model, two MCMC chains each with 20,000 iterations were run. Convergence in
the models was assessed visually from the plots generated, as well as from the potential scale
reduction factor (psrf) of the Gelman Rubin statistic. Adequate sample size was confirmed
using the effective sample size (i.e. > 400) of the resulting chains.
Microscopy results as well as qPCR data were treated as binary data, with 0 representing
negative results and 1 representing positive results, and were modelled as discrete variables. At
the time of the qPCR testing, cut-off Ct values were determined based on the results of the no-
template controls. A conservative cut-off value was set at 36 cycles and this cut-off was applied
across all three targets to ensure that amplification artefacts such as small-scale cross-contami-
nation or the degradation of probes did not interfere with the qPCR [32]. Samples with Ct
values� 36 were designated positive for the respective target, while those with Ct values > 36
or no amplification were considered negative. In the one instance where amplification of a no-
template control occurred (Ct value of 37 for target cap), the Ct cut-off value was adjusted to
35 for any samples in the same extraction batch. Samples in which all three targets amplified
below the cut-off were considered positive for B. anthracis. The maximum Ct value of the
three values obtained for the different genetic targets was chosen to represent the Ct value for
the respective sample. Results of no-template controls were also included in the model, as they
provide a form of prior information for the model (true negatives for B. anthracis).
The sensitivity and specificity of qPCR were obtained in two ways. In the first, they were
derived from the model using a Ct cut-off value of 36. In the second, sensitivity and specificity
were estimated by optimising the Ct cut-off. Optimising the balance between sensitivity and spec-
ificity yields a threshold for which the total highest sensitivity and specificity are obtained [33].
In assessing the agreement (or disagreement) between different observers, Kappa statistics
were used to measure inter-observer agreement and to quantify the consistency of the agree-
ment observed [34]. Kappa statistics for inter-observer agreement, the agreement between the
TVLA technique and azure B as well as PMB stain microscopy were computed using the irr
package [35] in R version 3.6.0 [30] (S2 File).
Results
Through the field surveillance platform, 367 suspected anthrax cases were investigated (S2
Table). Blood smears, whole blood, blood swabs and flies were available from 152 (41%), 102
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(28%), 138 (38%) and 30 (8%) carcasses, respectively. By contrast, skin samples could be
obtained from the vast majority of carcasses (n = 325 or 89%). All five sample types were only
obtained from 16 (4%) carcasses.
The majority of cases were sheep (67.3%), followed by goats and cattle (ca. 10% each; S3
Table) and donkeys (4.6%). Non-livestock species included Giraffa camelopardalis (giraffe),
Connochaetes taurinus (wildebeest), Equus burchellii (zebra) and Loxodonta africana (ele-
phant), while species identity could not be established for 22 suspected cases. The majority of
carcasses (80%) had been opened prior to the diagnostic investigation.
Microscopy
The majority (100/152, 65.8%) of the smear samples were collected less than 24 hours after the
death of the animal, while > 98% were collected within a week. The timing of smear collection
was not associated with the sensitivity of the microscopy tests, as samples collected more than
24 hours after death were equally likely to be falsely negative as samples collected within 24
hours (for azure B, OR = 1.00, 95% CI (0.98–1.02) (S3 File). The proportion of positives, based
on the detection of capsule, was higher with PMB or azure B stains than with Giemsa or Rapi-
Diff II (Table 1 and S4 Table).
Microscopy using PMB or azure B had high sensitivity and specificity. In contrast, staining
with Giemsa or Rapid Diff II gave poor sensitivity (Table 2).
The LCM allowed the estimation of the sensitivity and specificity of the staining tests as
well as the prevalence of anthrax in the samples. The overall prevalence of B. anthracis in the
samples was estimated to be 68% (95% CI: 62–73%).
Inter-observer agreement was nearly perfect for azure B and PMB (PABAK scores of 0.94
and 0.95, respectively, with 1.0 representing perfect agreement) when both observers evaluated
the same slide. Likewise, when different slides were stained and observed separately, inter-
observer agreement was near perfect for azure B with a PABAK score of 0.94 (S2 File).
Table 1. Detection of Bacillus anthracis among samples from 152 suspected anthrax cases evaluated with three
stains and a subset of 102 cases evaluated with four stains. PMB = polychrome methylene blue.
Technique Number of positive samples
Three stain comparison (n = 152) Four stain comparison (n = 102)
qPCR 90 (59.2%) 69 (67.6%)
PMB N/A 62 (60.8%)
Azure B 81 (53.3%) 62 (60.8%)
Giemsa 14 (9.2%) 11 (10.8%)
Rapi-Diff II 15 (9.9%) 12 (11.8%)
https://doi.org/10.1371/journal.pntd.0008655.t001
Table 2. Estimated sensitivity and specificity of microscopy techniques for detection of Bacillus anthracis in
blood smears, using a latent class model (LCM), assuming no reference standard. PMB = polychrome methylene
blue.
Stain Median sensitivity (posterior 95% credible
intervals)
Median specificity (posterior 95% credible
intervals)
Azure B (n = 152) 90.8% (83.9–96.4%) 98.5% (96.0–100.0%)
PMB (n = 102) 91.6% (84.3–97.3%) 98.3% (95.3–100.0%)
Giemsa (n = 152) 16.2% (9.2–24.0%) 99.2% (97.2–100.0%)
Rapi-Diff II
(n = 152)
17.5% (10.3–25.5%) 99.2% (97.3–100.0%)
https://doi.org/10.1371/journal.pntd.0008655.t002
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Quantitative PCR
Detection of B. anthracis in different sample types. Overall, 61% of samples (457/747)
tested positive based on DNA amplification of the three targets at Ct� 36. The majority (90%)
of samples in which at least one target was detected showed successful amplification of the
other two targets as well (Table 3). In many cases, florescence was detected for the lef target
earliest (39.3% of samples where amplification of all three targets occurred) when compared to
the cap (6.7%) and chromosomal targets (6.4%). For the other samples (47.6%) Ct values were
the same either between two or all three targets. For the lef target, samples passed the Ct 1.6
cycles earlier on average compared to both cap and the chromosomal target PL3.
Quantitative PCR using smear samples yielded the highest combined sensitivity and speci-
ficity. For all sample types, the sensitivity and specificity of qPCR were high (87.0% − 98.6%) at
the optimal sample-specific threshold (Table 4). The only exception was fly samples, which
only had a sensitivity of 19.2%.
Assessing the possibility of stained smears as starting materials for PCR. DNA extracts
from unstained blood smears from confirmed anthrax cases (n = 15) had lower average Ct
values (23.76 +/- 4.85) than those from smears stained with azure B, PMB, Giemsa or Rapi-
Diff II (25.82 +/- 4.45, 26.71 +/- 4.81, 28.50 +/- 5.45 and 26.64 +/- 5.01, respectively). Four of
the positive controls (one per stain), which had been pre-treated with formalin, showed no
amplification.
Discussion
Our study demonstrates that microscopy using azure B staining on field-prepared blood
smears from suspected anthrax-affected animal carcasses from endemic areas yields very high
Table 3. Number (and percentage) of anthrax-suspected samples with detection of none, one, two, or all three
DNA targets at a qPCR cycle threshold�36.
Sample type Number of targets amplified
0 1 2 3
Blood smear (n = 152) 57 (37.5) 2 (1.3) 4 (2.6) 89 (58.6)
Whole blood (n = 102) 37 (36.3) 5 (4.9) 1 (0.1) 59 (57.8)
Blood swab (n = 138) 43 (31.2) 5 (3.6) 7 (5.1) 83 (60.1)
Skin (n = 325) 82 (25.2) 15 (4.6) 5 (1.5) 223 (68.6)
Flies (n = 30) 20 (66.7) 4 (13.3) 3 (10.0) 3 (10.0)
Total samples (n = 747) 239 (32.0) 31 (4.1) 20 (2.7) 457 (61.2)
https://doi.org/10.1371/journal.pntd.0008655.t003
Table 4. Optimal cycle threshold (Ct) cut-off values and corresponding sensitivity and specificity for detecting B. anthracis with quantitative polymerase chain reac-






Median sensitivity at Ct
cut-off of 36 (posterior 95%
credible intervals)
Median specificity at Ct












152 97.8% (93.0–99.7%) 95.1% (87.0–98.9%) 32 96.2% (90.3–99.2%) 98.6% (93.2–99.9%)
Whole
blood
102 87.0% (77.4–93.9%) 89.3% (77.2–96.2%) 39 93.4% (85.6–97.9%) 87.0% (74.4–94.9%)
Blood
swab
138 87.0% (78.6–93.1%) 93.2% (84.2–98.2%) 37 89.2% (81.3–94.5%) 92.5% (82.4–98.0%)
Skin 325 93.6% (88.9–96.8%) 94.4% (86.3–98.8%) 37 94.7% (90.2–97.9%) 94.7% (87.0–98.9%)
Flies 30 19.2% (5.1–42.2%) 93.5% (73.2–99.8%) 36 19.2% (5.1–42.2%) 93.5% (73.2–99.8%)
https://doi.org/10.1371/journal.pntd.0008655.t004
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sensitivity and optimal specificity. This technique largely outperforms other stains (Giemsa or
Rapi-Diff II) commonly used in laboratories in endemic areas, and is advantageous compared
to the gold standard stain–Polychrome Methylene Blue (PMB)–because it can be used imme-
diately after preparation (in comparison to PMB, which requires at least a year of maturation).
Azure B staining is also robust, with good consistency of results between users. However,
given that in many anthrax-endemic areas carcasses are either consumed or scavenged, blood
is often not available for diagnostic confirmation by microscopy. In our study, tissue samples,
particularly skin samples, were commonly available from suspect carcasses. We show that
these samples enable pathogen detection with high sensitivity and specificity using direct
qPCR, even when stored for up to several months at ambient temperature. This sample type
can therefore offer a good alternative when microscopy is not possible. These practical solu-
tions will be of considerable value to the surveillance and control of anthrax in other high-risk
areas that face similar challenges.
Our results demonstrate that azure B provides a user-friendly alternative to the officially
recommended PMB stain for microscopic detection of B. anthracis, matching it on scientific
criteria (sensitivity, specificity, and inter-observer agreement) and out-performing it on conve-
nience criteria. Smear stain microscopy using azure B fulfils most of the ASSURED criteria.
Microscopy is more affordable, user friendly and rapid than culture or PCR; however, deliver-
ability of microscopy under field conditions can be hampered by the limited availability of the
officially recommended PMB stain. This limitation is overcome by azure B, which is commer-
cially available and convenient to prepare and use because it does not require aging. Inter-
observer agreements for both azure B and PMB indicated that the tests are robust to variability
that could occur among multiple observers, and when staining was performed by different
individuals–including those with minimal experience–or even laboratories. Thus, azure B is a
suitable alternative stain to PMB with major advantages for the detection of B. anthracis in
blood smear samples from the field. In contrast, the sensitivities of Giemsa and Rapi-Diff II for
detecting the capsule of B. anthracis were poor and their use should be discouraged for anthrax
confirmation.
One major limitation of smear stain microscopy is the need for access to blood samples. In
many affected areas in Africa and Asia, anthrax carcasses are consumed by the local population
[14–16] or by scavengers [17,18], limiting the availability of fresh samples for diagnostic test-
ing, as confirmed by our findings. This also limits the value of other promising rapid tests,
such as lateral flow tests conducted on blood samples [36]. Out of the total number of sus-
pected cases investigated, we could only obtain blood smears for 41%. Therefore, alternative
sample materials and diagnostic methods must be considered for anthrax surveillance in
endemic areas. Other diagnostic methods include culture and PCR, neither of which would be
ASSURED at field level. However, both culture and PCR are considered sensitive and specific,
and the requisite facilities and equipment may be available at national level. Because of the
need for higher containment facilities when conducting culture of B. anthracis, PCR is more
user-friendly. Although our work was carried out in a BSL 3 laboratory, this is not a strict
requirement for anthrax diagnostic methods. Procedures that do not generate aerosols or large
quantities of the pathogen can be safely carried out in lower containment laboratories [6]. In
the case of DNA extraction, this would ideally be done within a biosafety cabinet. There are
ongoing concerted efforts to build the capacities of national laboratories in endemic countries
to carry out molecular detection of B. anthracis from clinical specimens [37]. We therefore
anticipate that this capacity will be widely available in low-income countries where anthrax is
endemic, providing unprecedented opportunities for anthrax surveillance and research. Com-
parisons between culture and PCR were not conducted as part of the current study due to the
lack of local capacity for B. anthracis culture. Rather, we focussed on the robustness of PCR to
PLOS NEGLECTED TROPICAL DISEASES Anthrax diagnostics in endemic low-resource areas
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008655 September 14, 2020 12 / 17
field conditions (lack of cold chain) and on its ability to deliver results from the available sam-
ple types. To our knowledge, this study is the first to demonstrate the value of qPCR, using
DNA extracted directly from samples, for the diagnosis of animal anthrax without the need for
prior culture.
The convenience criteria we aimed to maximise were those of sample availability, while
assessing the suitability of sample storage at ambient temperature to overcome the lack of stor-
age infrastructure in field conditions characteristic of endemic and remote communities in
low-income countries. Skin tissue was available in the majority of cases (89%), and from twice
as many suspected anthrax cases as blood smears. The high sensitivity and specificity of qPCR
using skin samples indicates that the collection of this sample material from suspect animal
carcasses has the potential to radically improve anthrax surveillance in endemic settings. PCR
using whole blood or swab samples had lower sensitivity and specificity than smear and skin
tissue samples, and these sample types suffered from the same challenges of limited availability
as described for blood smears; as such, these sample types have minimal utility for routine
anthrax surveillance compared to blood smears or skin tissues. While outside the scope of this
study, further research would be valuable to assess whether simplified DNA extraction proto-
cols from tissues (i.e. without the need of a homogeniser) would result in similar test accuracy
and thereby minimise the amount of specialised equipment required.
We found that it is not only possible to detect B. anthracis from samples stored at ambient
temperature for up to six months, but that the pathogen can be detected with high sensitivity
and specificity. The ability of B. anthracis to form spores may be responsible for this observa-
tion, since the DNA sequestered in spores is protected from damage. The higher analytical sen-
sitivity of the lef target, which is carried by the PXO1 plasmid, is likely associated with the high
number of copies of this plasmid typically present in the B. anthracis genome. The PXO2 plas-
mid which carries the cap target has been found to be present in much lower copy numbers
[38]. No comparisons were made between the outcomes (i.e. sensitivity and specificity) of
qPCR for samples stored at ambient temperature and those stored using cold chain. Notwith-
standing, the diagnostic results were similar to those obtained using stain microscopy, which is
based on a different method of pathogen detection (DNA vs presence of capsule). This suggests
that sample storage at ambient temperature is unlikely to have a major impact on the detection
of B. anthracis.
The poor sensitivity of qPCR for detecting B. anthracis from fly samples indicates that they
are not useful diagnostic materials, at least in the kind of environments our study was con-
ducted in. The potential to use flies as an indicator of the infection status of associated car-
casses depends on the flies being exposed to B. anthracis from those carcasses, either through
ingestion or as mechanical vectors [39]. Thus, flies not having picked up spores will falsely
indicate an infected carcass as negative. The analysis of fly samples has been shown to provide
insights into the epidemiology of anthrax in areas where carcasses are even more challenging
to find and sample. Hoffmann et al. [40] were able to detect the DNA of anthrax-causing B.
cereus in fly samples, which allowed them to better define the geographical distribution of this
pathogen in dense tropical forests in West Africa. DNA was detected in only 5% of the 784 fly
samples tested in that study; given the low sensitivity of qPCR we estimated with fly samples,
the true prevalence of anthrax could be much higher than what Hoffmann et al. reported [40].
Where blood smears can be taken from suspected anthrax cases, microscopy using azure B
stained slides should be the method of choice for case confirmation. Furthermore, we found
that stained smear samples can also be used reliably for PCR detection. This could be useful in
retrospective studies or for molecular investigation of confirmed anthrax cases. However, fixa-
tion of blood smears with formalin, which crosslinks and damages DNA, reduced the sensitiv-
ity of the qPCR assay, as suggested by previous studies [41]. By contrast, use of azure B, PMB,
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Giemsa or Rapi-Diff II does not preclude the use of PCR, although the sensitivity of detection
is also slightly reduced. PCR testing on stained smears may not only be useful for the confirma-
tion of anthrax, but may have potential use for strain typing e.g. identifying canonical single
nucleotide polymorphisms (SNPs) in the B. anthracis genome [42].
Conclusion
This study, conducted in field conditions in an anthrax-endemic area, has shown that micros-
copy using azure B in place of PMB is highly sensitive and specific for detecting B. anthracis
in blood smears from animal carcasses, and more user-friendly because of the availability of
azure B. However, tissue samples were more readily available from carcasses than blood smears
and B. anthracis was detected from them with high sensitivity and specificity using qPCR. In
the event of a suspected anthrax case in an animal, smear samples (when available) for use in
microscopy and PCR, and skin tissues for PCR are most likely to yield accurate diagnostic
results for anthrax surveillance in endemic areas where the lack of infrastructure impedes cold
chain storage. We propose practical and feasible solutions to the widely recognised challenges
of anthrax surveillance in the most affected areas. Our approaches will therefore be of value to
a range of endemic contexts by providing insights into disease occurrence that can be used to
inform human and animal health policy and targeted anthrax control efforts.
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